SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Gilead Reaches National Agreement for Lyvdelzi in Canada

Gilead reached a national agreement for Lyvdelzi (seladelpar), a treatment for primary biliary cholangitis. The agreement brings Canadians with the condition one step closer to a new treatment option.

GILD

Related stories